Career development of future researchers is a core focus of CREATE. The overall goal of career development is to identify and train investigators who will be future leaders in pulmonary fibrosis research.
Research training opportunities include:
Grants are allocated via a competitive application process.
More opportunities coming soon.
The Pulmonary Fibrosis Australasian Clinical Trials (PACT) Network offered a 2022 PACT Grant-in-Aid for Investigator Led Pulmonary Fibrosis Clinical Research, valued at up to AUD30,000. Applications closed 19th April 2022 and are currently being reviewed.
An initiative of the Centre for Research Excellence in Pulmonary Fibrosis, supported by Lung Foundation Australia’s Hope Research Fund. The CREATE Hope Clinical Fellowship in Pulmonary Fibrosis was offered in early 2022. This Fellowship was awarded to Dr Ingrid Cox from the Menzies Institute for Medical Research and University of Tasmania.
A CREATE Hope Scientific Fellowship in Pulmonary Fibrosis was offered in 2021 for commencement in 2022. This Fellowship was awarded to Dr Gang Liu from the University of Technology Sydney and the Centenary Institute.
In 2020 and 2021, CREATE Grants-in-Aid were offered to specifically support new collaborations for PF research amongst CREATE ECRs from two or more institutions. One grant was awarded in 2020 and two more in 2021.
The Pulmonary Fibrosis Australasian Clinical Trials (PACT) Network offered the second annual PACT Grant-in-Aid for Investigator-led Pulmonary Fibrosis Clinical Research in February 2021.
The Grant-in-Aid valued at $30,000 was awarded to Dr Yet Hong Khor from Austin Health to assist investigator led Pulmonary Fibrosis clinical research.
Thanks to a donation from Lung Foundation Australia's Hope Research Fund, the CRE-PF and LFA offered two PhD scholarships for a new or ongoing student, each for $28,000 for the academic year 2021.
Congratulations to to the winners of the CREATE Hope PhD scholarships: Joanna Lee (Self-management for pulmonary fibrosis: what does it mean and how might it help?) and Claudia Sim (Targeting fibrosis with relaxin – a new therapeutic strategy for IPF and silicosis), both from Monash University.
Lung Foundation Australia funding opportunities for 2021 have now closed.